ASSESSING THE EFFECTIVENESS OF A NEW ANTI-DIABETIC FORMULATION (DIAKURE)
Phase 1
- Conditions
- Health Condition 1: null- DIABETIC
- Registration Number
- CTRI/2015/06/005891
- Lead Sponsor
- RVS COLLEGE OF PHARMACEUTICAL SCIENCES
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 80
Inclusion Criteria
1. Patients diagnosed with type 2 diabetes mellitus.
2. Patient who are keeping up their regular follow-up visits.
3. Patients who are competent enough to consider informed consent.
Exclusion Criteria
1. Patients who are very frail.
2. Patients in their gestational and lactating period.
3. Patients diagnosed with cardiac and psychiatric disorders.
4. Patients above and below the age group.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Blood sugar levels (both random and fasting)Timepoint: Once in 15 days.
- Secondary Outcome Measures
Name Time Method Glycosylated Hemoglobin (HbA1c) <br/ ><br>BMITimepoint: Once in 60 days.